ERBB2 and neoplasm: Immunohistochemistry results showed CDX-2 (+), HER2 (0), E-Cad (+), CD31 (no intravascular tumor embolus), D2-40 (no lymphatic vessel tumor embolus), S-100 (no neural invasion), Ki-67 (60%), CK-Pan (+), and AB-PAS (+).